Skip to main content

Ulcers, Duodenal and Gastric

4
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
4
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

ViiV Healthcare
ViiV HealthcareNC - Durham
2 programs
2
Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation onePhase 1
Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation onePhase 1
Piramal Pharma
Piramal PharmaMumbai, India
2 programs
2
Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation onePhase 1
Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation onePhase 1
GSK
GSKLONDON, United Kingdom
2 programs
Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation onePHASE_11 trial
Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation onePHASE_11 trial
Active Trials
NCT01847404Completed24Est. Jun 2013
NCT01847417Completed24Est. Jul 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GSKTest 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one
GSKTest 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one

Clinical Trials (2)

Total enrollment: 48 patients across 2 trials

NCT01847417GSKTest 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one

Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed Conditions

Start: May 2013Est. completion: Jul 201324 patients
Phase 1Completed
NCT01847404GSKTest 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one

Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions

Start: May 2013Est. completion: Jun 201324 patients
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.